SEC Filing Summary: Bio-Rad Laboratories, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bio-Rad Laboratories, Inc. on December 4, 2018. The filing addresses corporate governance matters regarding the scheduling of the company's 2019 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly procedural and contains no financial performance data.
Material Changes
The Board of Directors has advanced the date of the 2019 Annual Meeting to Tuesday, April 23, 2019. This date is more than 30 days prior to the anniversary of the 2018 Annual Meeting, triggering specific disclosure requirements under Rule 14a-5(f) of the Exchange Act.
Guidance, Outlook, and Corporate Actions
Due to the change in the meeting date, new deadlines for stockholder proposals and director nominations have been established:
- Rule 14a-8 Proposals: Must be received by the Corporate Secretary on or before January 4, 2019.
- Bylaw Nominations/Proposals: Written notice must be received between December 24, 2018 and January 23, 2019.
- Meeting Details: The exact time and location will be specified in the upcoming proxy statement.
Key Facts for Investor Verification
- Verify the final time and location of the 2019 Annual Meeting once the proxy statement is released.
- Confirm the deadline for submitting Rule 14a-8 proposals is January 4, 2019.
- Note the narrow window (Dec 24, 2018 – Jan 23, 2019) for submitting advance notice nominations under the company's Bylaws.